Literature DB >> 1564675

Cognitive effects of beta blockers.

J E Dimsdale1, R P Newton.   

Abstract

This study examined the effects of atenolol and metoprolol on neuropsychologic functioning, mood, sedation, and sleep. Following tapering of antihypertensive medication and a 3-wk placebo washout, 35 hypertensive patients were randomized to receive double-blind either atenolol or metoprolol for 4 wk. There was no consistent evidence that beta blocker treatment was associated with a deleterious effect on neuropsychologic functioning. The neuropsychologic effects of the drugs did not differ. There were also no significant changes in mood as assessed by the Profile of Mood States as a consequence of treatment with a beta blocker. However, there was a trend for patients receiving metoprolol to report a poorer mood profile. There was no overall or differential drug effect on deep sleep or sedation. On both drugs, however, patients complained of disturbing dreams (p less than 0.04); however, the two drugs did not differ in this regard. On both medications patients had substantial complaints of fatigue; however, it is inappropriate to attribute this to the medication since there were equivalent complaints on placebo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1564675     DOI: 10.1016/0022-3999(92)90087-i

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

Review 1.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

2.  Fatigue varies by social class in African Americans but not Caucasian Americans.

Authors:  Wayne A Bardwell; Stephen C Burke; KaMala S Thomas; Christian Carter; Kimberly Weingart; Joel E Dimsdale
Journal:  Int J Behav Med       Date:  2006

3.  Inflammation and sleep in healthy individuals.

Authors:  Paul J Mills; Roland von Känel; Daniel Norman; Loki Natarajan; Michael G Ziegler; Joel E Dimsdale
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

Review 4.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 5.  Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Authors:  Mirella Russo; Matteo A De Rosa; Dario Calisi; Stefano Consoli; Giacomo Evangelista; Fedele Dono; Matteo Santilli; Alberto Granzotto; Marco Onofrj; Stefano L Sensi
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.